Cetaphil AI Visibility Market Strategy Report - Body Care Brands

Answer Capsule

Cetaphil holds third place in AI-generated body care recommendations with 72.05% valid recommendation coverage in October 2026, behind CeraVe at 91.06% and Neutrogena at 81.37%. The brand is visible in 77.19% of qualified AI answers but converts that presence into a valid recommendation less often than its two closest competitors. Cetaphil's clearest strength is placement quality: its top-three rate rose to 55.70% in October 2026 from 46.90% in July 2026. Its clearest weakness is rank-one conversion, where it captures the first recommendation slot in only 8.17% of observations compared to CeraVe's 53.61%. The biggest opportunity sits in closing the gap between top-three placement and first-position selection across high-intent discovery prompts.

Who This Report Is For

This report is written for Cetaphil's brand leadership, ecommerce and digital strategy teams, and category managers who need to understand how AI systems position the brand at the recommendation stage in body care discovery. It is also relevant for retail partners and agency teams managing Cetaphil's search, content, and authority strategy across AI platforms.

Report Card

Executive Summary

Cetaphil enters October 2026 as the third-ranked body care brand in AI-generated recommendations, holding 72.05% valid recommendation coverage across 526 qualified observations. The brand appears in some form in 77.19% of qualified AI answers, but the gap between appearing and being recommended is 5.14 percentage points, meaning Cetaphil is mentioned without receiving recommendation credit in a meaningful share of responses.

The brand's recommendation coverage declined 1.15 percentage points from July 2026, when it stood at 73.20%. That movement falls within normal month-to-month variation, and the category-level picture shows Cetaphil holding its position rather than losing ground decisively. However, the gap to CeraVe, the category leader, remains substantial at 19.01 percentage points.

Cetaphil's strongest signal in October 2026 is placement quality improvement. Its top-three rate climbed to 55.70% from 46.90% in July 2026, an 8.80 percentage point gain. This means that when Cetaphil does earn a recommendation, it is increasingly landing in the first three positions rather than appearing lower in the list.

The brand's clearest weakness is rank-one conversion. Cetaphil holds the first recommendation position in only 8.17% of qualified observations, compared to CeraVe's 53.61% and Neutrogena's 8.37%. Despite a top-three rate nearly identical to Neutrogena's 56.65%, Cetaphil converts those placements into first-position recommendations at a similar low rate. This suggests that AI systems recognize Cetaphil as a valid option but rarely position it as the single best choice.

Platform-level data shows Cetaphil's strongest recommendation behavior on AI Overviews, where it holds 76.76% valid recommendation coverage and a 14.08% rank-one rate. Its weakest platform performance appears on Gemini, where coverage drops to 70.49% and rank-one rate falls to zero. The brand also shows zero rank-one placements on ChatGPT despite 72.31% coverage there.

The category's buyer-intent distribution is narrow. All 526 qualified observations in October 2026 fell into the Brand Recommendation cluster. No qualified observations addressed pricing, value, or multi-brand comparison questions, meaning the benchmark cannot yet show how AI systems position Cetaphil on cost or head-to-head comparisons.

What Cetaphil Is Winning

Questions This Section Answers

• Where has Cetaphil made the biggest placement-quality gains in AI body care recommendations?
• Which platforms currently show Cetaphil's strongest rank-one and coverage performance?
• What does Cetaphil's sentiment profile look like across AI responses?

Cetaphil's strongest evidence-backed win is its top-three placement improvement. The brand's top-three rate rose from 46.90% in July 2026 to 55.70% in October 2026, an 8.80 percentage point gain that moved it closer to Neutrogena's 56.65% and well above Kiehl's 22.24%. This indicates that when AI systems do recommend Cetaphil, they are increasingly placing it among the first three options rather than lower in the list.

The brand's second win is its AI Overviews performance. On that platform, Cetaphil holds 76.76% valid recommendation coverage, the highest of any platform tracked, and a 14.08% rank-one rate. AI Overviews represents the largest single-platform opportunity pool in the dataset, and Cetaphil performs comparatively well there.

Cetaphil also shows zero negative mentions across all 526 observations. Its net sentiment score of 0.9483 reflects 385 positive mentions, 21 neutral mentions, and no negative framing. The brand's framing quality in AI responses is strong, even where recommendation conversion lags.

A fourth win is Cetaphil's Perplexity performance. The brand holds a 14.93% rank-one rate on Perplexity, its highest first-position rate across any platform, alongside 77.61% valid recommendation coverage. This suggests that Perplexity's retrieval and synthesis patterns favor Cetaphil more often than other platforms do.

Where Cetaphil Has the Clearest AI Visibility Gaps

Questions This Section Answers

• How far behind CeraVe is Cetaphil on first-position recommendations?
• Why does Cetaphil record zero rank-one placements on ChatGPT and Gemini despite strong presence there?
• What can't Cetaphil assess because comparison and pricing clusters produced no qualified observations?

Cetaphil's most significant gap is rank-one conversion. The brand holds the first recommendation position in only 8.17% of qualified observations, while CeraVe captures 53.61%. This 45.44 percentage point gap means that even when both brands appear in the same AI response, CeraVe is far more likely to be named first. The competitive displacement effect is substantial: CeraVe is not just present, it is preferred.

The second gap is platform inconsistency. Cetaphil shows zero rank-one placements on ChatGPT and Gemini despite holding 72.31% and 70.49% valid recommendation coverage on those platforms respectively. On ChatGPT, the brand appears in 76.92% of observations but never captures the top slot. On Gemini, it appears in 77.05% of observations with the same result. This pattern suggests that ChatGPT and Gemini recognize Cetaphil as a valid option but consistently position other brands ahead of it.

The third gap is the presence-to-recommendation conversion rate. Cetaphil appears in 77.19% of qualified observations but receives valid recommendation credit in only 72.05%. The 5.14 percentage point difference represents observations where the brand is mentioned but not recommended. By comparison, CeraVe appears in 96.01% of observations and receives recommendation credit in 91.06%, a 4.95 percentage point gap. The conversion efficiency is similar, but Cetaphil's lower base means fewer total recommendation opportunities.

The fourth gap is cluster coverage. The benchmark currently measures only one active cluster, Best Body Care Brands Discovery & Evaluation. Cetaphil has no visibility data for comparison or pricing clusters because those clusters produced no qualified observations. This means the brand cannot yet assess how AI systems position it against competitors in head-to-head or value-focused prompts.

Biggest Opportunity

Questions This Section Answers

• How can Cetaphil convert its top-three placements into rank-one recommendations on ChatGPT and Gemini?
• Which prompt types carry the most commercial weight for closing the rank-one gap?

Cetaphil's biggest opportunity is converting its top-three placements into rank-one recommendations on ChatGPT and Gemini. The brand already achieves 55.70% top-three placement overall, but its rank-one rate on ChatGPT and Gemini is zero. Closing that gap would move Cetaphil from being a recognized option to being the preferred recommendation on two of the highest-volume platforms in the dataset.

The path to that conversion runs through the evidence layer. AI systems synthesize recommendations from retrievable sources, and the benchmark's citation data shows that editorial publishers, retailer pages, and the brand's own domain all contribute to the information environment. Cetaphil's owned content and third-party coverage may currently support inclusion in recommendation lists without providing the comparative or authority signals that would justify first-position selection.

The prompt types most relevant to this opportunity are dermatologist-recommendation prompts and sensitive-skin or therapeutic-use prompts, which appear in the cluster's prompt examples. These are high-intent queries where buyers are actively seeking a specific recommendation, and where first-position placement carries the most commercial weight.

Competitive Landscape

Questions This Section Answers

• Who leads AI body care recommendations, and where does Cetaphil land in the standings?
• How does Cetaphil's placement and rank-one rate compare with Neutrogena and CeraVe?

CeraVe holds dominant recommendation-stage strength in the body care category, with a 91.06% valid recommendation coverage rate and a 53.61% rank-one rate that far exceeds any other tracked brand. Cetaphil sits in third place, behind Neutrogena on coverage but ahead of Kiehl's, Sun Bum, Origins, Kopari Beauty, and Billie.

Average recommended rank covers rank-eligible recommendations only.

Cetaphil's position in the table shows a brand with top-three placement nearly identical to Neutrogena but a slightly lower rank-one rate and a better average recommended rank of 2.63 compared to Neutrogena's 3.06. The data indicates that when Cetaphil is recommended, it tends to land in the second or third position rather than the first, while Neutrogena's recommendations are more evenly distributed across positions.

Prompt Evidence

Questions This Section Answers

• Which prompt and platform combinations produced Cetaphil's strongest rank-one signals?
• Where did Cetaphil appear in AI answers without converting to first-position recommendations?

ChatGPT / Best Body Care Brands Discovery & Evaluation Prompt: "Which is the no. 1 face moisturizer?" Result: Cetaphil received a valid recommendation in 72.31% of ChatGPT observations but captured zero rank-one placements, suggesting the brand is listed as an option without being named first.

Perplexity / Best Body Care Brands Discovery & Evaluation Prompt: "Which body wash is recommended by a dermatologist?" Result: Cetaphil achieved its highest rank-one rate on Perplexity at 14.93%, indicating that dermatologist-recommendation prompts on this platform favor the brand more often than other query types.

Gemini / Best Body Care Brands Discovery & Evaluation Prompt: "Which is the best moisturizer to use?" Result: Cetaphil appeared in 77.05% of Gemini observations with 70.49% valid recommendation coverage, but recorded zero rank-one placements, showing presence without first-position conversion.

AI Overviews / Best Body Care Brands Discovery & Evaluation Prompt: "What are the top 10 best skincare brands?" Result: Cetaphil held 76.76% valid recommendation coverage and a 14.08% rank-one rate on AI Overviews, its strongest platform-level performance in the dataset.

What CiteWorks Studio Would Do Next

Phase 1: AI Visibility Market Discovery Audit Map Cetaphil's prompt-level visibility across all six platforms, identifying which specific queries produce recommendations and which produce mentions without recommendation credit.

Phase 2: Recommendation Readiness Plan Prioritize the ChatGPT and Gemini rank-one gap by identifying the comparative and authority signals those platforms appear to weight when selecting a first-position brand.

Phase 3: Owned Answer Layer Buildout Strengthen Cetaphil's owned content to provide clearer comparative positioning, dermatologist-endorsement signals, and product-specific evidence that AI systems can retrieve and synthesize.

Phase 4: Citation / Authority Layer Development Expand the brand's presence in the editorial, retailer, and community sources that AI systems cite most frequently, particularly those that support first-position recommendation framing.

Phase 5: Monthly AI Visibility and Recommendation Tracking Track Cetaphil's coverage, top-three rate, rank-one rate, and sentiment across platforms to measure whether the rank-one gap narrows over time.

Why This Matters

AI-generated recommendations are becoming a primary discovery channel for body care buyers. When a consumer asks an AI system which moisturizer or body wash to use, the answer shapes the shortlist before the buyer ever visits a retailer or search engine. Cetaphil's 72.05% valid recommendation coverage means the brand is present in most AI answers, but its 8.17% rank-one rate means it is rarely the first option named.

The difference between being listed and being recommended first is commercially significant. A brand that appears third in a recommendation list competes for attention against the two brands named ahead of it. A brand that appears first captures the default choice. Cetaphil's data shows a brand that has earned recognition but has not yet earned preference at the recommendation stage.

The next move is targeted correction of the prompt, page, and citation layers that shape AI responses. Cetaphil's owned content, third-party coverage, and source footprint all contribute to how AI systems frame the brand. Improving the comparative clarity, authority signals, and retrievability of those sources is the path from top-three placement to first-position recommendation.

Core Metrics

Sentiment Score

Questions This Section Answers

• Why is mention volume alone a misleading measure of Cetaphil's AI visibility?
• What do Cetaphil's neutral mentions mean for recommendation strength?

Sentiment Score = (positive mentions × 1 + neutral mentions × 0 + negative mentions × -1) / total mentions

Cetaphil's sentiment score for October 2026 is 0.9483, calculated from 385 positive mentions, 21 neutral mentions, and zero negative mentions across 406 total mentions.

This score matters because unclassified mention counts are misleading. A brand that appears in 406 AI responses but is framed negatively in half of them is not in the same position as a brand with the same mention count and no negative framing. Cetaphil's zero negative mentions indicate that AI systems do not currently associate the brand with cautionary or critical framing.

Share of voice is a diagnostic metric, not a business KPI. A positive recommendation, a neutral reference, a cautionary mention, and a competitor-displaced mention are not equal in commercial value. Cetaphil's 21 neutral mentions represent responses where the brand was referenced without positive or negative framing, such as factual listings or context mentions. These do not carry the same recommendation weight as the 385 positive mentions.

Counting all mentions as wins is bad measurement. Cetaphil's 406 mentions include 27 responses where the brand appeared but did not receive valid recommendation credit. Classified sentiment is required before interpreting AI visibility because it separates genuine recommendation strength from mere presence.

Sentiment by Platform

Methodology

1. This report is a benchmark-based analysis of Cetaphil's AI recommendation visibility in the body care category for October 2026. It is not a client implementation case study and does not imply that CiteWorks Studio caused any benchmark outcome.
2. The reporting window is October 2026, with comparison data from July 2026, August 2026, and September 2026 where available.
3. Six AI platforms were tracked: ChatGPT, Copilot, Gemini, Perplexity, AI Overviews, and AI Mode. All six platforms produced qualified observations in October 2026.
4. The benchmark produced 526 qualified observations in October 2026, down from 623 in July 2026. The qualified denominator contracted as more prompts were filtered as irrelevant.
5. Eight brands were tracked: Billie, CeraVe, Cetaphil, Kiehl's, Kopari Beauty, Neutrogena, Origins, and Sun Bum.
6. One public high-intent cluster was active in October 2026: Best Body Care Brands Discovery & Evaluation (C01). Two additional clusters, Body Care Brand Comparisons & Alternatives (C02) and Body Care Brand Pricing & Value (C03), produced no qualified observations.
7. Stage 0 extraction retained the query, AI surface, answer, brand outcome, recommendation placement, sentiment, and where exposed, citations or attributable evidence sources.
8. A mention is counted when Cetaphil appears in an AI response in any form, including factual references, listings, or recommendations.
9. A valid recommendation is counted when Cetaphil receives explicit recommendation credit from the AI system, as distinct from a neutral mention or comparison anchor.
10. Top-three rate is the share of qualified observations where Cetaphil appears in the first three recommendation positions. Rank-one rate is the share where Cetaphil is the first recommendation named.
11. Average recommended rank covers rank-eligible recommendations only. Cetaphil's average recommended rank of 2.63 reflects its position when it receives valid rank credit.
12. Limitations: The benchmark does not measure market share, attributable sales, every possible AI response, organic-search ranking, social mention volume, or causality from a metric movement alone. The qualified denominator contracted from July 2026 as more prompts were filtered as irrelevant, which affects brand-level percentages. Small-count brands carry percentages that should be read with absolute counts in mind.

See How AI Is Recommending Your Brand

Cetaphil's benchmark position shows a brand with strong presence and improving placement quality but a persistent gap in first-position recommendation conversion. A company-level AI visibility audit can map the specific prompts, platforms, and source patterns that shape how AI systems frame Cetaphil against competitors, and identify the highest-priority opportunities to close the rank-one gap.